VEGF: A critical player in neurodegeneration

Journal of Clinical Investigation

Volumn 113, Issue 1, 2004, Pages 14-18

  Storkebaum, Erik ^a   Carmeliet, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANGIOGENIC FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A;

ANGIOGENESIS; BRAIN REGION; CELL PROLIFERATION; DEGENERATIVE DISEASE; DRUG EFFECT; EXPERIMENTAL MODEL; GENE DELETION; GENE TRANSFER; HUMAN; MOLECULAR INTERACTION; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE REGENERATION; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SCHWANN CELL; TISSUE PERFUSION; ANIMAL; BIOLOGICAL MODEL; GENETICS; NERVE DEGENERATION; PHYSIOLOGY;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85047694286     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20682     Document Type: Review

References (55)

1. Carmeliet, P. 2003. Angiogenesis in health and disease. Nat. Med. 9:653-660.
2. Oosthuyse, B., et al. 2001. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:131-138.
3. Cleveland, D.W., and Rothstein, J.D. 2001. From Charcot ro Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2:806-819.
4. Lambrechts, D., et al. 2003. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34:383-394.
5. Carmeliet, P., et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:435-439.
6. Kobari, M., Obara, K., Watanabe, S., Dembo, T., and Fukuuchi, Y. 1996. Local cerebral blood flow in motor neuron disease: correlation with clinical findings. J. Neurol. Sci. 144:64-69.
7. Waldemar, G., Vorstrup, S., Jensen, T.S., Johnsen, A., and Boysen, G. 1992. Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study. J. Neurol. Sci. 107:19-28.
8. Storkebaum, E., et al. 2003. VEGF, a modifier of motor neuron degeneration in SOD1 G93A mice, protects against motor neuron loss after spinal cord ischemia: evidence for a vascular hypothesis. Program No. 602.11. 2003. Abstract Viewer/Itinerary Planner. Society for Neuroscience. Washington, DC, USA. http://sfn.scholarone.com.
9. Deckel, A.W., and Duffy, J.D. 2000. Vasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntington's disease patients. Brain Res. 872:258-261.
10. Kalaria, R.N. 2002. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc. Dis. 13:48-52.
11. Buijs, P.C., et al. 1998. Effect of age on cerebral blood flow measurement with ungated two-dimensional phase contrast MR angiography in 250 adults. Radiology. 209:667-674.
12. Tarkowski, E., et al. 2002. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol. Aging. 23:237-243.
13. Samii, A., Unger, J., and Lange, W. 1999. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats. Neurosci. Lett. 262:159-162.
14. Sondell, M., Lundborg, G., and Kanje, M. 1999. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19:5731-5740.
15. Thomas, P.S., et al. 2003. SBMA motor neuronopathy in AR YAC CAG100 transgenic mice may involve altered expression of VEGF. Program No. 413.2. 2003. Abstract Viewer/Itinerary Planner. Society for Neuroscience. Washington, DC, USA. http://sfn.scholarone.com.
16. Matsuzaki, H., et al. 2001. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J. 15:1218-1220.
17. Svensson, B., et al. 2002. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J. Cereb. Blood Flow Metab. 22:1170-1175.
18. Li, B., Xu, W., Luo, C., Gozal, D., and Liu, R. 2003. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res. Mol. Brain Res. 111:155-164.
19. Sondell, M., and Kanje, M. 2001. Postnatal expression of VEGF and its receptor flk-1 in peripheral ganglia. Neuroreport. 12:105-108.
20. Jin, K.L., Mao, X.O., and Greenberg, D.A. 2000. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. U. S. A. 97:10242-10247.
21. Jin, K.L., Mao, X.O., and Greenberg, D.A. 2000. Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. J. Mol. Neurosci. 14:197-203.
22. Ogunshola, O.O., et al. 2002. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 277:11410-11415.
23. Silverman, W.F., Krum, J.M., Mani, N., and Rosenstein, J.M. 1999. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience. 90:1529-1541.
24. Schratzberger, P., et al. 2000. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med. 6:405-413.
25. Krum, J.M., Mani, N., and Rosenstein, J.M. 2002. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience. 110:589-604.
26. Forstreuter, F., Lucius, R., and Mentlein, R. 2002. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J. Neuroimmunol. 132:93-98.
27. Zerlin, M., and Goldman, J.E. 1997. Interactions between glial progenitors and blood vessels during early postnatal corticogenesis: blood vessel contact represents an early stage of astrocyte differentiation. J. Comp. Neurol. 387:537-546.
28. Palmer, T.D., Willhoite, A.R., and Gage, F.H. 2000. Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 425:479-494.
29. Leventhal, C., Rafii, S., Rafii, D., Shahar, A., and Goldman, S.A. 1999. Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol. Cell. Neurosci. 13:450-464.
30. Black, J.E., Isaacs, K.R., Anderson, B.J., Alcantara, A.A., and Greenough, W.T. 1990. Learning causes synaptogenesis, whereas motor activity causes angiogenesis, in cerebellar cortex of adult rats. Proc. Natl. Acad. Sci. U. S. A. 87:5568-5572.
31. Kokaia, Z., and Lindvall, O. 2003. Neurogenesis after ischaemic brain insults. Curr. Opin. Neurobiol. 13:127-132.
32. Monje, M.L., Mizumatsu, S., Fike, J.R., and Palmer, T.D. 2002. Irradiation induces neural precursor-cell dysfunction. Nat. Med. 8:955-962.
33. Yang, K., and Cepko, C.L. 1996. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J. Neurosci. 16:6089-6099.
34. Yourey, P.A., Gohari, S., Su, J.L., and Alderson, R.F. 2000. Vascular endothelial cell growth factors promote the in vitro development of rat photoreceptor cells. J. Neurosci. 20:6781-6788.
35. Jin, K., et al. 2002. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 99:11946-11950.
36. Zhu, Y., Jin, K., Mao, X.O., and Greenberg, D.A. 2003. Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression. FASEB J. 17:186-193.
37. Louissaint, A., Jr., Rao, S., Leventhal, C., and Goldman, S.A. 2002. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron. 34:945-960.
38. Sun, Y., et al. 2003. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111:1843-1851. doi:10.1172/JC1200317977.
39. Facchiano, F., et al. 2002. Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J. Neurosurg. 97:161-168.
40. Simovic, D., Isner, J.M., Ropper, A.H., Pieczek, A., and Weinberg, D.H. 2001. Improvement in chronic ischemic neuropathy after intramuscular phVEGF 165 gene transfer in patients with critical limb ischemia. Arch. Neurol. 58:761-768.
41. Schratzberger, P., et al. 2001. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107:1083-1092.
42. Sondell, M., Lundborg, G., and Kanje, M. 1999. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res. 846:219-228.
43. Yasuhara, T., et al. 2003. Vascular endothelial growth factor has a neuroprotective effect on Parkinson's disease. Program No. 233.6. 2003. Abstract Viewer/Itinerary Planner. Society for Neuroscience. Washington, DC, USA. http://sfn.scholarone.com.
44. Zhang, Z.G., et al. 2000. VEGF enhances angiogenesis and promotes bloodbrain barrier leakage in the ischemic brain. J. Clin. Invest. 106:829-838.
45. Harrigan, M.R., Ennis, S.R., Sullivan, S.E., and Keep, R.F. 2003. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir. (Wien). 145:49-53.
46. Hayashi, T., Abe, K., and Itoyama, Y. 1998. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J. Cereb. Blood Flow Metab. 18:887-895.
47. Yang, Z.J., et al. 2002. Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia. J. Neurosci. Res. 70:140-149.
48. van Bruggen, N., et al. 1999. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104:1613-1620.
49. Croll, S.D., Goodman, J.H., and Scharfman, H.E. 2003. Vascular endothelial growth factor (VEGF) in seizures: a double edged sword. In Recent advances in epilepsy research. D.K. Binder and H.E. Scharfman, editors. Kluwer Academic/Plenum Publishers New York, New York, USA. In press.
50. Vagnucci, A.H., Jr., and Li, W.W. 2003. Alzheimer's disease and angiogenesis. Lancet. 361:605-608.
51. Farkaz, E., De Jong, G.I., de Vos, R.A., Jansen Steur, E.N., and Luiten, P.G. 2000. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol. (Berl). 100:395-402.
52. Boulton, A.J., and Malik, R.A. 1998. Diabetic neuropathy. Med. Clin. North Am. 82:909-929.
53. Kalimo, H., Ruchoux, M.M., Viitanen, M., and Kalaria, R.N. 2002. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 12:371-384.
54. Krupinski, J., Kaluza, J., Kumar, P., Kumar, S., and Wang, J.M. 1994. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 25:1794-1798.
55. Koperek, O., et al. 2002. Disease-associated prion protein in vessel walls. Am. J. Pathol. 161:1979-1984.